Tinnitus News

We are delighted to report that Neuromod Devices Ltd. has been granted approval by the Food and Drugs Administration (FDA) to supply the Lenire tinnitus therapy system to patients in the U.S. This is the first time that a bimodal neuromodulation system has ever been grated FDA approval for the treatment of subjective tinnitus and […]

Earlier this week a new study investigating the impact of long COVID was published by University College Cork (UCC)1. This study involved 988 participants with 90% of participants reporting that they still have not returned to their pre COVID level of health and that their current symptoms were not present prior to contracting the virus. […]

In a recent study published in The Laryngoscope researchers assessed the incidence of new-onset tinnitus after coronavirus disease 2019 (COVID-19) vaccination. The growing prevalence of vaccine hesitancy and anxiety about the messenger ribonucleic acid (mRNA) COVID-19 vaccine’s side effects has become an important global health concern. In the present study, researchers determined the proportion of patients who […]

In a recent study published in The Laryngoscope researchers assessed the incidence of new-onset tinnitus after coronavirus disease 2019 (COVID-19) vaccination. The growing prevalence of vaccine hesitancy and anxiety about the messenger ribonucleic acid (mRNA) COVID-19 vaccine's side effects has become an important global health concern.

The results of the second randomised controlled trial (RCT) examining the efficacy of the Lenire tinnitus therapy system have now been published in the respected journal "Nature - Scientific Reports".

New AI-enabled hearing aids from Starkey can help isolate sounds that a user would prefer to hear from complex background noise.

A new “real-word”, 20 patient study (Buechner et al 2022) investigating the effectiveness of Lenire in alleviating tinnitus symptoms has been shown that over a 6-12 week treatment period, 86.2% of participants reported a clinically significant improvement in their tinnitus Nb id rather say 8 out of 10 than 86.2%.

Biotech company Frequency Therapeutics is seeking to reverse hearing loss with a new form of regenerative therapy.

Visual Snow Syndrome (VSS) is an uncommon (estimated prevalence of around 2% in the UK) neurological condition that causes individuals to see black, white or transparent dots in their field of vision.

Starkey Hearing Technologies have just launched a new product range that is specifically designed to be used by audiologists in order to improve hearing whilst having the capability to provide bespoke tinnitus sound therapy.

Starkey Hearing Technologies have just launched a new product range that is specifically designed to be used by audiologists in order to improve hearing whilst having the capability to provide bespoke tinnitus sound therapy.

This paper describes the results from a double blinded randomised control trial examining the efficacy of bimodal neuromodulation for the treatment of bothersome subjective tinnitus.